Outpost Medicine

company

About

Outpost Medicine is a biopharmaceutical company

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$41M
Industries
Biopharma,Biotechnology,Medical,Pharmaceutical
Founded date
Jan 1, 2016
Number Of Employee
11 - 50
Operating Status
Close

At Outpost, they are committed to developing novel therapeutics for the treatment of gastrointestinal and urologic disorders. The company's lead clinical-stage product candidate is in development for the treatment of overactive bladder (OAB) and irritable bowel syndrome (IBS).

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$41M
Outpost Medicine has raised a total of $41M in funding over 2 rounds. Their latest funding was raised on Mar 14, 2016 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 14, 2016 Series A $41M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Outpost Medicine is funded by 1 investors. Takeda are the most recent investors.
Investor Name Lead Investor Funding Round
Takeda Series A